Treatment Pathways and Guidance
BNOS is keen to assist its members in highlighting for them current guidelines for management of CNS neoplastic disease.
The following clinical links might be helpful to members.
Dataset for tumours of the central nervous system, including the pituitary gland (4th Edition) (Royal College of Pathologists: Standards and datasets for reporting cancers, January 2016)
INTERNATIONAL BEST PRACTICE GUIDELINES
First clinical guidelines for management of recurrent chordoma published in the Annals of Oncology (Chordoma Foundation Team, July 2017)
European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma (The Lancet Oncology, June 2017)
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO) (SNO Neuro-oncology February 2017)
EANO guidelines for the diagnosis and treatment of meningiomas (published in Lancet Oncology September 2016)
EANO has published two sets of guidelines for management of glioma:
For high grade glioma –
For low grade glioma –
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas (The Lancet Oncology, June 2011)
ESTRO-ACROP guideline “target delineation of glioblastomas” (Radiotherapy Oncology, January 2016)
USA / AUSTRALIA
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria (SNO Neuro-oncology April 2017)
“Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors” Report of the Quality Standards Subcommittee of the American Academy of Neurology.
Datasets For Central Nervous System (International Collaboration On Cancer Reporting)